CytomX Therapeutics Inc
NASDAQ:CTMX

Watchlist Manager
CytomX Therapeutics Inc Logo
CytomX Therapeutics Inc
NASDAQ:CTMX
Watchlist
Price: 1.03 USD 1.98% Market Closed
Market Cap: 80.5m USD
Have any thoughts about
CytomX Therapeutics Inc?
Write Note

CytomX Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CytomX Therapeutics Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
CytomX Therapeutics Inc
NASDAQ:CTMX
Revenue
$126.6m
CAGR 3-Years
24%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$55.5B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$28.3B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Revenue
$32.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.6B
CAGR 3-Years
14%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.8B
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
18%

See Also

What is CytomX Therapeutics Inc's Revenue?
Revenue
126.6m USD

Based on the financial report for Sep 30, 2024, CytomX Therapeutics Inc's Revenue amounts to 126.6m USD.

What is CytomX Therapeutics Inc's Revenue growth rate?
Revenue CAGR 5Y
16%

Over the last year, the Revenue growth was 68%. The average annual Revenue growth rates for CytomX Therapeutics Inc have been 24% over the past three years , 16% over the past five years .

Back to Top